Anti-Factor H Autoantibodies in a Fifth Renal Transplant Recipient with Atypical Hemolytic and Uremic Syndrome
Open Access
- 16 April 2009
- journal article
- case report
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (5) , 1223-1229
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiencyBlood, 2008
- Development of anti-factor H auto-antibodies genetically predisposed in atypical HUSMolecular Immunology, 2007
- Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndromeBlood, 2007
- Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLOS Genetics, 2007
- A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degenerationNature Genetics, 2006
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeBlood, 2006
- Outcome of Renal Transplantation in Patients with Non–Shiga Toxin–Associated Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2006
- Atypical haemolytic uraemic syndrome and mutations in complement regulator genesSpringer Seminars in Immunopathology, 2005
- Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic SyndromeJournal of the American Society of Nephrology, 2005